Category Archive for: ‘Multaq’

Multaq Use Limited by FDA

A recent study showed Multaq doubled the risk of heart-related complications in patients with permanent atrial fibrillation. The study, conducted bythe drugmaker,  Sanofi, showed higher rates of heart attack, stroke and death in certain patients. While the FDA did not remove Multaq from the market, they recommended restricting the use of the drug to patients with the short term form …

Read More